European Journal of Ophthalmology · 2019 · 45 citations · 30 references
MedicineImmunologyOphthalmologyClinical ImmunologyImmunopathologyOcular ImmunologyAge-related Macular DegenerationComplement SystemImmunopathology Of The EyeMacular DegenerationMacular DiseaseMacular DisordersAdvanced Age-related Macular DegenerationAge-related Macular Degeneration BiomarkersC3 Complement LevelsComplement BiomarkersComplement System ActivationComplement System DysregulationEnzyme-linked Immunosorbent Assay (Elisa)Neovascular Macular Degeneration
PURPOSE: To examine the role of systemic activation of the complement system (assessed by levels of circulating C3a, Ba, and sC5b-9) in patients (n = 122) with advanced age-related macular degeneration, geographic atrophy, and neovascular age-related macular degeneration, compared with cataract controls (n = 27). METHODS: Plasma complement factors were measured using enzyme-linked immunosorbent assays. Statistical analysis included univariate and multivariate logistic regression (p < 0.05). RESULTS: Adjusted for age, the odds ratios of C3a and sC5b-9 for any advanced age-related macular degeneration were 1.78 (95% confidence interval = 1.16-2.73, p < 0.01) and 1.20 (95% confidence interval = 1.04-1.39, p = 0.01), respectively. We found a significantly elevated adjusted odds ratio of C3a (adjusted odds ratio = 1.71, 95% confidence interval = 1.12-2.60, p = 0.01) and sC5b-9 (adjusted odds ratio = 1.22, 95% confidence interval = 1.04-1.43, p = 0.01) for neovascular age-related macular degeneration. Adjusted for age, neither C3a, sC5b-9, nor Ba were associated with geographic atrophy. CONCLUSION: We suggest a role for elevated plasma levels of C3a and sC5b-9 in patients with neovascular age-related macular degeneration. The study's results reinforce the need for more investigation to assess the impact of therapeutic interventions targeted at the complement signaling pathways in age-related macular degeneration.
30
Complement Factor H Polymorphism in Age-Related Macular Degeneration
Robert J. Klein, Caroline J. Zeiss, Emily Y. Chew et al. · Science · 2005 · 4.5K citations
Medicine, Immunology, Ophthalmology +14
Complement Factor H Polymorphism and Age-Related Macular Degeneration
Albert O. Edwards, Robert Ritter, Kenneth J. Abel et al. · Science · 2005 · 2.4K citations
Medicine, Immunology, Ophthalmology +14
Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration
Jonathan L. Haines, Michael A. Hauser, Silke Schmidt et al. · Science · 2005 · 2.4K citations
Medicine, Genetics, Ophthalmology +14
Gregory S. Hageman, Don H. Anderson, Lincoln V. Johnson et al. · Proceedings of the National Academy of Sciences · 2005 · 2K citations · Full text
Clinical Classification of Age-related Macular Degeneration
Frederick L. Ferris, Charles P. Wilkinson, Alan C. Bird et al. · Ophthalmology · 2013 · 1.8K citations · Full text